期刊文献+

激素非依赖性前列腺癌T淋巴细胞亚群及NK细胞水平分析 被引量:3

Analyze the level of T lymphocyte subsets and NK cells with androgen-independent prostate cancer
下载PDF
导出
摘要 目的观察激素非依赖性前列腺癌患者的细胞免疫水平。方法激素非依赖性前列腺癌患者36例,以处于激素依赖期前列腺癌患者39例为对照组,分别抽取静脉血,按程序处理后采用流式细胞术检测患者外周血T淋巴细胞亚群及NK细胞水平。结果与对照组比较,激素非依赖性前列腺癌患者CD3+T、CD4+T及CD8+T水平均明显下降(P<0.05),CD(16+56)+N水平亦下降明显(P<0.05),而CD4+/CD8+T比值上升,但差异无统计学意义;多脏器转移患者CD3+T、CD4+T、CD8+T及CD(16+56)+N水平下降更明显,与其他组分别比较差异有统计学意义(P<0.05)。结论激素非依赖性前列腺癌患者T淋巴细胞亚群水平及NK细胞活性明显下降,监测激素非依赖性前列腺癌患者的细胞免疫水平有助于判断患者病情变化和指导治疗。 Objective To investigate cell immunity of androgen-independent prostate cancer(AIPC).Methods 36 cases of AIPC patients and 39 cases of androgen-dependent prostate cancer(regarded as control group) whose blood samples were collected in this study,T lymphocyte subsets and natural killer cells(NK cells) levels were detected by flow cytometry method.Results Compared with the control group,CD3+、CD4+、CD8+ levels of AIPC all decreased significantly,CD(16+56)+ also decreased obviously,and the ratio of CD4+/CD8+T increased but without significant difference.The CD3+、CD4+、CD8+ and CD(16+56)+ N levels of these AIPC patients who had multiple organ metastasis decreased more obviously in this study.Conclusion s The levels of T lymphocyte subsets and NK cells in AIPC patients decrease obviously,so monitor their cell immunity is helpful to estimate the conditions of AIPC and to guide the treatment methods.
出处 《现代泌尿生殖肿瘤杂志》 2010年第5期231-233,共3页 Journal of Contemporary Urologic and Reproductive Oncology
基金 广东省中医药管理局立项课题(2008329)
关键词 前列腺肿瘤 T淋巴细胞亚群 Prostatic neoplasms T-lymphocyte subsets
  • 相关文献

参考文献5

二级参考文献51

  • 1王建功,闫天中.皮质醇与雄激素非依赖前列腺癌的关系[J].实用医药杂志,2004,21(7):595-596. 被引量:5
  • 2Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin, 2002, 52: 154-179.
  • 3Wingo PA, Cardinez CJ, Landis SH, et al . Long-term trends in cancer mortality in the United States, 1930-1998. Cancer, 2003,97( 12 Suppl): 3133-3275.
  • 4Taplin ME, Rajeshkumar B, Halabi S, et al . Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J Clin Oncol, 2003, 21 : 2673-2678.
  • 5Ceraline J, Cruchant MD, Erdmann E, et al. Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer. Int J Cancer, 2004, 108: 152-157.
  • 6Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplification during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res, 1999,59 : 803-806.
  • 7Kang HY,Yeh S, Fujimoto N, et al. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem, 1999,274 :8570-8576.
  • 8Miyamoto H, Yeh S, Wilding G, et al. Promotion of agonist activity of antiandrogens by the of androgen receptor coactivator,ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA, 1998, 95:7379-7384.
  • 9Yeh S,Lin HK, Kang HY, et al. From HER2/Neu signal cascade to androgen receptor and its coactivator: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA, 1999, 96: 5458-5463.
  • 10Gregory CW, He B, Johnson RT, et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res, 2001,61:4315-4319.

共引文献19

同被引文献54

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部